Background of the Study: Hypertension or high blood pressure is a complex public health problem. It refers to the Persistent elevation of Arterial blood pressure as hypertension gradually increases the pressure of blood flowing through the arteries thus can cause damaged and narrowed arteries. There occurs stiffness of arteries because the space in the arteries is narrower, the same amount of blood passing through them increases the blood pressure. Veins can constrict to reduce their capacity to hold blood, forcing more blood into the arteries. As a result, blood pressure increases. The higher the blood pressure in a community the higher is the risk of other health complications. Blood pressure elevations are associated with an increased risk of cardiovascular diseases such as cardiac arrest or coronary heart diseases. Starting at a blood pressure of 115/ 75 mmHg, every increase of 20mmHg in systolic blood pressure (SBP) and/or increase of 10mmHg in diastolic blood pressure (DBP) is associated with the doubling of the risk of death (Lewington,2002). Aims and Objectives: This research work was aimed to provide Pregnancy Induced Hypertension (PIH), a common complication affecting maternal and fetal health. This hospital-based study at SKIMS Soura Srinagar was aimed to investigate the prevalence of PIH and its associated maternal and fetal outcomes in a cohort of 150 patients. Methods: Data was collected from the medical records of pregnant women diagnosed with PIH between June 2023 and November 2023. Demographic information, clinical characteristics and neonatal outcomes were analyzed. The prevalence of PIH was found to be 40%. Maternal complications such as Preeclampsia, Eclampsia, Chronic hypertension, Gestational hypertension and Preeclampsia Superimposed on Chronic Hypertension were observed in 67%, 10.99%, 3.33%, 13.33%, 7% of cases respectively. Adverse fetal outcomes including preterm birth, low birth weight and IUGR were noted in less than 10% of pregnancies complicated by PIH. Gravidity shows the strong relation with PIH with multigravida at higher risk of mortality and morbidity due to PIH (about 39 out of 60 hypertensive pregnant ladies which accounts for 65% of total patients). A study was conducted to investigate the impact of secondhand smoking exposure on patients diagnosed with various pregnancy-related conditions, including low fetal weight, transient eclampsia, eclampsia, preeclampsia, and gestational hypertension. Results: The study observed a total of 32 patients with 4 diagnosed with transient eclampsia, 5 with eclampsia, 15 with pre-eclampsia, and 8 with gestational hypertension. Through meticulous analysis, researchers sought to elucidate the potential correlation between exposure to secondhand smoke and the severity or incidence of these conditions among pregnant individuals. The findings of this research endeavor hold significant implications for public health policies and interventions aimed at mitigating the adverse effects of secondhand smoking on vulnerable populations, particularly pregnant women and their unborn children. In the observed cohort, it was noted that the most administered drug among patients was Gravidol, prescribed at a dosage range of 50-100mg per day. Gravidol, known for its efficacy in managing various pregnancy-related conditions, was carefully administered under the supervision of healthcare professionals to ensure optimal maternal and fetal outcomes. Conclusion: The conclusions drawn from this study emphasize the critical importance of early detection, vigilant monitoring, and proactive management of Pregnancy-Induced Hypertension (PIH) to mitigate adverse maternal and fetal outcomes. Through comprehensive management protocols, including pharmacotherapy, dietary modifications, and lifestyle interventions, healthcare teams can effectively control PIH and minimize its detrimental effects on maternal and fetal health. Overall, the study underscores the imperative for proactive and integrated care approaches to PIH, emphasizing the importance of early intervention and ongoing monitoring to optimize pregnancy outcomes and ensure the well-being of both mother and baby.
